You are here:

MD Meymac

Your Trusted Partner in Oral Dosage Form Production

Originally founded by Bristol Myers Squibb in 1988, the production site in Meymac was acquired by the Prange Pharma Group in 2024. Our facility combines deep pharmaceutical expertise with advanced technologies to support your oral dosage form projects. We offer trustworthy partnerships based on reliability, flexibility, and a strong commitment to our customers.

MD Meymac - Icon tablets

2 bn
tablets

per annum

MD Meymac - Icon capsules

400 mio.
capsules

per annum

MD Meymac - Icon sachets

50 mio.
sachets

per annum

MD Meymac - Icon blister

60 mio.
blister

per annum

MD Meymac - Icon bottle

250k
bottles

per annum

MD Meymac - Vision and mission

Our Vision and Mission

At MD Meymac, we strive to build long-term, reliable, and sustainable partnerships with our customers. Based on our strategy, our guiding principles reflect our commitment to delivering the highest quality of our products, while fostering growth with both existing and new customers.

MD Meymac - Vision and mission

MD Meymac Career

Join Our Team!

At MD Meymac, we are always looking for talented, passionate, and target-driven people to join our team. If you are looking to work in a dynamic and innovative environment where your contributions truly matter, you have come to the right place!

MD Meymac - Career